New app in Tyrol: Telemedicine for young leukemia patients
Tirol clinics use the "EPROTECT" app for telemedicine for young leukemia patients. The app enables video and daily self -assessment to improve therapy.
New app in Tyrol: Telemedicine for young leukemia patients
Young leukemia patients in Tyrol benefit from new technology
In Tyrol there is an exciting innovation to support young leukemia patients, which includes an age group from zero to 18 years. The Tyrol clinics are increasingly relying on telemedicine to help these patients. A mobile app has been in use since 2023, which enables the medication settings to be made via video calls. This app is not only practical, but also plays an important role in the daily self -assessment of the patients.
Those responsible recently presented this initiative at a press conference in Innsbruck. It was emphasized that the "EPROTECT" app in its form and methodology is unique for the Austrian market. Health Councilor Cornelia Hagele (ÖVP) said that the app was developed especially for children and adolescents in order to take their needs into account as best as possible. The survey function enables young patients to indicate how they feel every day, which is crucial for the course of their therapy.
The influence of the app on the treatment
The implementation of this app has significant advantages for the affected patients and their families. One of the main strengths of video advice is the time saving: parents and children no longer have to travel for every doctor's appointment. Instead, you can easily follow the treatment from home. This is particularly important for children who may be in a weaker state of health or who have to go through an intensive therapy.
The app also promotes the personal commitment of young patients in their therapy process. By regularly documenting their experiences and well -being, the children feel more active into their treatment. This active participation can further increase therapy success because doctors are able to react faster to changes in health.
The Tyrol Clinics in charge are convinced that this innovation has a positive impact on the recovery chances of young leukemia patients. "We see it as our duty to use the latest technologies to ensure the best possible supply," added Hagele. The fusion of medical competence and digital technology opens up new ways in the treatment of diseases and shows how telemedicine can play an important role in the future of healthcare.
This development could be a model for other clinics in Austria and beyond. It remains to be seen how the technology could develop and possibly also be transferred to other clinical pictures in order to offer the patient even more individual care. The progress that this app represents could make a decisive contribution to improving the quality of life for many young leukemia patients.
Interesting information can be found for more details on this topic here.